(Q51811099)

12 April 2018

title

Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment. (English)

1 reference

12 April 2018

main subject

cognitive dysfunction

1 reference

1

1 reference

12 April 2018

Vesa Oikonen

4

1 reference

12 April 2018

Juha O. Rinne

5

object named as

Juha O Rinne

1 reference

12 April 2018

author name string

Sari Laatu

2

1 reference

12 April 2018

Riitta Parkkola

3

1 reference

12 April 2018

Juhani Ruutiainen

6

1 reference

12 April 2018

publication date

3 March 2011

1 reference

12 April 2018

Multiple Sclerosis Journal

published in

1 reference

12 April 2018

volume

17

1 reference

12 April 2018

issue

8

1 reference

12 April 2018

page(s)

931-938

1 reference

12 April 2018

Cognitive impairment in multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Neuropsychiatric symptoms in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Cognitive dysfunction and emotional-behavioural changes in MS: the potential of positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

The relationship between MRI and PET changes and cognitive disturbances in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Cholinergic denervation occurs early in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Age-associated leukoaraiosis and cortical cholinergic deafferentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Assessment of spatial normalization of PET ligand images using ligand-specific templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Evaluation of simplified kinetic analyses for measurement of brain acetylcholinesterase activity using N-[11C]Methylpiperidin-4-yl propionate and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Comparison of two brief neuropsychological batteries in people with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Cortical reorganisation in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Acute cognitive effects of donepezil in young, healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Butyrylcholinesterase activity in multiple sclerosis neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399613

21 January 2018

Identifiers

DOI

10.1177/1352458511399613

1 reference

12 April 2018

1 reference

12 April 2018